Method for treating complementary determining regions 3 (CDRs3) of B cell antigen receptor H chains

A treatment method, B cell technology, applied in the direction of biochemical equipment and methods, microbial measurement/inspection, etc., can solve the problems of reform of treatment methods, failure to fully clarify the immune mechanism of ESRD, etc., and achieve the effect of deepening understanding

Inactive Publication Date: 2017-11-14
眭维国 +3
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above studies have not fully elucidated the immune mechanism of ESRD, and the treatment methods have not fundamentally changed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for treating complementary determining regions 3 (CDRs3) of B cell antigen receptor H chains

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] In order to make the above objects, features and advantages of the present invention more comprehensible, specific implementations of the present invention will be described in detail below in conjunction with the accompanying drawings. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. However, the present invention can be implemented in many other ways different from those described here, and those skilled in the art can make similar improvements without departing from the connotation of the present invention, so the present invention is not limited by the specific embodiments disclosed below.

[0028] see figure 1 , an embodiment of the present invention is a method for processing B cell antigen receptor H chain CDR3, which includes the following steps.

[0029] S110, setting up an experimental group and a control group, each group including several peripheral blood samples fro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for treating complementary determining regions 3 (CDRs3) of B cell antigen receptor H chains. The method comprises the following steps: setting an experimental group and a control group, wherein each group comprises a plurality of parts of peripheral blood samples which are dissimilar to a human body and get away from the human body; separating B cells of the peripheral blood samples, and respectively extracting deoxyribonucleic acid (DNA) in the B cells of the peripheral blood samples; adopting a multiplex polymerase chain reaction (PCR) technique to amplify the CDRs3 of the B cell antigen receptor H chains; carrying out high-throughput sequencing on the CDRs3 of the B cell antigen receptor H chains, and carrying out DNA analysis on the B cell antigen receptor H chains in the experimental group and the control group. The method for treating the CDRs3 of the B cell antigen receptor H chains is reasonable and feasible in design, and can be used for effectively acquiring information, taken as intermediate results, about renal transplant recipients at the perioperative period and further verifying, analyzing and researching the information so as to help to study the pathogenesis of a rejection reaction and guide the individual rational application of immunosuppressive drugs, thus being beneficial to improvement of the treatment of patients with end-stage renal disease.

Description

technical field [0001] The invention relates to a method for acquiring end-stage renal disease information as an intermediate result, in particular to a processing method for B cell antigen receptor H chain CDR3. Background technique [0002] End stage renal disease (ESRD) refers to the end stage of various chronic kidney diseases. It is similar to the concept of uremia, but the diagnostic criteria are different. It is generally believed that when the ball filtration rate drops to 15mL / (min.1.73m 2 ) can be diagnosed below. That is to say, when chronic kidney disease reaches stage 5, it enters the stage of end-stage renal disease. Patients with ESRD are often accompanied by extremely low immune function, and severe infection is the main reason for their poor quality of life and death. Therefore, understanding the immune status of patients with chronic renal insufficiency at different stages is of great significance for clinical guidance. There may be no obvious discomfort...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
CPCC12Q1/6869C12Q2537/143C12Q2525/191C12Q2535/122
Inventor 眭维国戴勇王磊薛雯
Owner 眭维国
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap